期刊文献+

鼻咽癌石蜡标本中筛选差异表达的miRNA 被引量:7

Selection of aberrant miRNA in paraffin specimens of nasopharyngeal cancer
下载PDF
导出
摘要 目的应用MicroRNAs(miRNAs)芯片技术筛选鼻咽癌石蜡标本组织中差异表达的miRNAs,研究与鼻咽癌相关的miRNAs。方法从2例鼻咽癌石蜡切片和相配对的正常鼻组织中提取总RNA,miRNA芯片检测miRNA表达情况,然后在37例鼻咽癌石蜡切片和正常鼻组织中,用Real-time RT-PCR(Taqman)对部分差异表达miRNA进行验证。结果芯片结果显示:与配对的正常鼻组织相比,有24个miRNAs在鼻咽癌中异常表达,其中8个miRNA高表达,16个miRNA低表达。用Real-time RT-PCR(Taqman)验证显示,hsa-miR-205在鼻咽癌中表达水平升高(P=0.021);hsa-miR-34c在鼻咽癌组织中表达水平降低(P=0.019)。结论 hsa-miR-205和hsa-miR-34c可能参与了鼻咽癌的发生过程。 Objective To screen aberrant miRNAs in nasopharyngeal carcinoma by miRNAs microarray. Methods Total RNA was extracted from nasopharyngeal cancer tissues and adjacent noncancerous tissues from paraffin sections. The miRNA expression profiles were analyzed using a mammalian miRNA microarray. Aberrant miRNAs were then verified by real-time RT-PCR in 37 nasopharyngeal cancer and nontumorous tissues. Results 24 aberrant miRNAs were identified by miRNA microarray, including 8-high expression of miRNAs and 16-low expression of miRNAs. Among them, the expression of hsa-miR-205 was verified to be higher( P=0.021) and hsa-miR-34c was identified to be significantly lower in the cancer tissues compared to the normal tissues(P=0.019). Conclusion hsa-miR-205 and hsa-miR-34c may be involved in the process of nasopharyngeal carcinogenesis.
出处 《广东药学院学报》 CAS 2014年第4期497-500,共4页 Academic Journal of Guangdong College of Pharmacy
基金 国家自然科学基金项目(81171447) 广东省自然科学基金项目(104518036002006310)
关键词 MIRNA hsa-miR-205 hsa-miR-34c 鼻咽癌 miRNA hsa-miR-205 hsa-miR-34c nasopharyngeal carcinoma
  • 相关文献

参考文献18

  • 1陈琼荣,夏和顺.WHO鼻咽癌分类介绍(NPC):中国抗癌协会湖北省分会肿瘤病理学专业委员会2006年学术报告会[R].中国:湖北孝感,2006.
  • 2王建玲,周慧芳,杨东.鼻咽癌治疗新进展[J].临床耳鼻咽喉头颈外科杂志,2011,25(21):1005-1008. 被引量:13
  • 3LIU Na, CUI Ruixue, SUN Ying, et al. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma[J]. Ant J Cancer,2014,134(6) : 1359-1368.
  • 4LIU Na, CHEN Nianyong, CUI Ruixue, et al. Prognostic value of a microRNA signature in nasophatyngeal carcinoma: a microRNA expression analysis[J]. Lancet Oncol,2012,13(6) :633-641.
  • 5SENGUPTA S, DEN B J A, CHEN I H, et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up- regulating mRNAs encoding extracellular matrix proteins [J].Proc Natl Acad Sci USA.2008,105(15):5874-597.
  • 6ZHANG Liming, DENG Tan, L1 Xiayu, et al. microRNA- 141 is involved in a nasopharyngeal carcinoma-related genes network[J] .Carcinogenesis,2010,31 (4) :559-566.
  • 7ZHANG Jufeng, WANG Ying, ZHEN Pingping, et al. Genome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell lines [J]. PLoS One, 2013,8 (1) :e54111.
  • 8LUO Zhaohui, ZHANG Liyang, LI Zheng, et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma[J] .BMC Med Genomics,2012,5:3.
  • 9MAJID S, SAINI S, DAR A A, et al. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer [ J ]. Cancer Res, 2011,71 (7) : 2611-2621.
  • 10KIM J S, YU S K, LEE M H, et al. MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells[J] .Mol Cells ,2013,35( 1 ) : 17-24.

二级参考文献26

  • 1高黎,易俊林,黄晓东,李素艳,罗京伟,徐国镇.鼻咽癌根治性放疗10年经验总结[J].中华放射肿瘤学杂志,2006,15(4):249-256. 被引量:144
  • 2赵充,卢丽霞,韩非,卢泰祥,黄劭敏,林承光,邓小武,崔念基.122例鼻咽癌单纯根治性调强放疗疗效分析[J].中华放射肿瘤学杂志,2006,15(5):364-368. 被引量:34
  • 3刘源,陈明,赵充,卢丽霞,韩非,包勇,黄劭敏,邓小武,卢泰祥,崔念基.鼻咽癌患者调强放射治疗后颞颌关节损伤及其影响因素[J].癌症,2007,26(1):64-67. 被引量:37
  • 4黄晓东,易俊林,高黎,徐国镇,金晶,杨伟志,卢泰祥,吴少雄,吴仁瑞,胡伟汉,谢伟长,韩非,高远红,高剑铭,潘建基,陈传本,朗锦义,李涛,董昱,付玉彬,樊林,李柏森,黎静,王晓怀,陈炳旭,高献书,张萍,吴湘玮,胡炳强.抗表皮生长因子受体单克隆抗体h—R3联合放疗治疗晚期鼻咽癌的Ⅱ期临床研究[J].中华肿瘤杂志,2007,29(3):197-201. 被引量:99
  • 5VIJAYAKUMAR S,CHEN G T Y. Implementation of three dimensional conformal radiation therapy: prospects, opportunities, and challenges [ J ]. Int J Radiat Oncol Biol Phys, 19 9 5,3 3 : 9 7 9 - 98 3.
  • 6BUFFER E B, THE B S, GRANT W H, et al. SMART (simultaneous modulated accelerated radia- tion therapy)boost: a new accelerated fracationation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy[J]. Int J Radiat Oncol Biol Phys,1999,45:21--32.
  • 7KAM M K, CHAU R M, SUEN J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and fea- sibility of dose escalation[J]. Int J Radiat Oncol Biol Phys, 2003,56 : 145 -- 157.
  • 8WONG F C,NG A W,LEE V H,et al. Whole-field simultaneous integrated-boost intensity-modulated ra- diotherapy for patients with nasopharyngeal carcino- ma[J]. Int J Radiat Oncol Biol Phys, 2010,76:138-- 145.
  • 9HAN L,LIN S J,PAN J J,et al. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy[J]. Clin J Cancer, 2010,29:145-150.
  • 10LEE A W,SZE W M,AU J S,et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience[J]. Int J Radiat Oncol Biol Phys, 2005,61 : 1107- 1116.

共引文献12

同被引文献57

  • 1周君,刘海玲,陈亦乐,文继舫,李龙,吴晓英.VEGF和miR-205及靶蛋白Ezrin和LaminA/C在卵巢癌中的表达及意义[J].中南大学学报(医学版),2014,39(2):142-150. 被引量:23
  • 2王旭丹,杨惠玲,郭禹标,梁志慧,赵睿颖,夏云飞,苏勇,Mong-Hong Lee,王瑾,郑芹.不同辐射抗拒鼻咽癌细胞微小RNA差异表达的研究[J].中国病理生理杂志,2007,23(6):1045-1048. 被引量:25
  • 3Heneghan H M,Miller N,Lowery A J,et al.Circulating microRNAs as novel minimally invasive biomarkers for breast cancer[J].Ann Surg,2010,251(3):499-505.
  • 4Ayaz L,G rür A,Yaro lu H Y,et al.Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma:potential early-detection markers for laryngeal squamous cell carcinoma[J].J Cancer Res Clin Oncol,2013,139(9):1499-1506.
  • 5Bryant R J,Pawlowski T,Catto J W F,et al.Changes in circulating microRNA levels associated with prostate cancer[J].Br J Cancer,2012,106(4):768-774.
  • 6Kelly B D,Miller N,Healy N A,et al.A review of expression profiling of circulating microRNAs in men with prostate cancer[J].BJU Int,2013,111(1):17-21.
  • 7Shigoka M,Tsuchida A,Matsudo T,et al.Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development[J].Pathol Int,2010,60(5):351-357.
  • 8Tsujiura M,Ichikawa D,Komatsu S,et al.Circulating microRNAs in plasma of patients with gastric cancers[J].Br J Cancer,2010,102(7):1174-1179.
  • 9Valladares-Ayerbes M,Reboredo M,Medina-Villaamil V,et al.Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer[J].J Transl Med,2012,10(1):186.
  • 10Redova M,Poprach A,Nekvindova J,et al.Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma[J].J Transl Med,2012,10:55.

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部